1. Home
  2. MIRM vs IRT Comparison

MIRM vs IRT Comparison

Compare MIRM & IRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$79.34

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Logo Independence Realty Trust Inc.

IRT

Independence Realty Trust Inc.

HOLD

Current Price

$17.47

Market Cap

3.9B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIRM
IRT
Founded
2018
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.9B
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
MIRM
IRT
Price
$79.34
$17.47
Analyst Decision
Strong Buy
Buy
Analyst Count
11
8
Target Price
$92.45
$21.56
AVG Volume (30 Days)
809.5K
2.7M
Earning Date
11-04-2025
02-11-2026
Dividend Yield
N/A
3.83%
EPS Growth
N/A
N/A
EPS
N/A
0.09
Revenue
$471,794,000.00
$662,924,000.00
Revenue This Year
$53.78
$4.21
Revenue Next Year
$19.91
$4.79
P/E Ratio
N/A
$195.01
Revenue Growth
53.66
3.19
52 Week Low
$36.88
$15.07
52 Week High
$82.58
$21.87

Technical Indicators

Market Signals
Indicator
MIRM
IRT
Relative Strength Index (RSI) 62.33 59.40
Support Level $77.99 $17.25
Resistance Level $82.58 $17.79
Average True Range (ATR) 3.21 0.24
MACD 1.03 0.05
Stochastic Oscillator 83.25 71.93

Price Performance

Historical Comparison
MIRM
IRT

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About IRT Independence Realty Trust Inc.

Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.

Share on Social Networks: